5 results
aps management diagnosis pharmacology apixaban aspirin cardiology cardiomyopathy eular2019 hematology lwmh obstetrics peripartum pregnancy rheumatology rivaroxaban thrombosis xainhibitors
Antiphospholipid Syndrome (APS) APS is a rare autoimmune disorder characterized by recurring blood clots resulting from antibodies
Syndrome (APS) ... to be present Treatment ... (EULAR Guidelines ... #Syndrome #APS ... #guidelines
Xa Inhibitors - Apixaban and Rivaroxaban Oral Xa inhibitors are recommended by CHEST as first-line for
patients with VTE treatment ... or Atrial Fibrillation ... requiring anticoagulation ... overview of the dosing ... #Rivaroxaban #Dosing
2019 EULAR recommendations for thrombosis in (Antiphospholipid Syndrome) APS Venous Thrombosis - Arterial Thrombosis INR Target Duration Recurrence Dr. Laurent ARNAUD
Syndrome) APS ... Venous Thrombosis - Arterial ... #Syndrome #APS ... management #EULAR2019 #guidelines ... rheumatology #hematology #treatment
Low-dose aspirin and low-molecular-weight heparin in lupus and Antiphospholipid Syndrome (APS) pregnancy • No previous history of
Syndrome (APS) ... thrombotic APS (arterial ... #Syndrome #APS ... pregnancy #Obstetrics #Anticoagulation ... Aspirin #LWMH #Dosing
Peripartum Cardiomyopathy - Summary 1. Definition • Towards the end of pregnancy to 5 months postpartum
Management during ... suggest prophylactic anticoagulation ... e.g., <50%), ESC guidelines ... Serial TTE and close ... management #cardiology #treatment
No results found for "Atrial Fibrillation Anticoagulation treatment syndrome antiphospholipid decisionaid guidelines dosing"
Try removing search terms or sorting by relevance
Or Upload an image for you and others searching for #Atrial #Fibrillation #Anticoagulation #treatment #syndrome #antiphospholipid #decisionaid #guidelines #dosing